Chao Wu (C Wu)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 79

Top Topics

Coronavirus Disease

Hepatitis B Virus

Top Venues

Alimentary pharmacology & therapeutics

Journal of viral hepatitis

PLoS neglected tropical diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Jian Wang, Shaoqiu Zhang, Zhiyi Zhang, Chao Wu, Rui Huang
Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D. Alimentary pharmacology & therapeutics 59 (9) (2024)
Yuxin Chen, Tiantian Zhao, Lin Chen, Guozhi Jiang, Yu Geng, Wanting Li, Shengxia Yin, Xin Tong, Yue Tao, Jun Ni, Qiuhan Lu, Mingzhe Ning, Chao Wu
SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients. mBio 15 (4) (2024)
Qi Gu, Shengxia Yin, Xin Tong, Fajuan Rui, Yixuan Zhu, Xiaoyan Ma, Rui Huang, Chao Wu, Jie Li
Current research insights into the role of CTLA-4 in hepatitis B virus (HBV) infection. Journal of viral hepatitis (2024)
Jian Wang, Yifan Pan, Ye Xiong, Chao Wu, Rui Huang
Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients. Alimentary pharmacology & therapeutics (2024)
Yuxin Chen, Tiantian Zhao, Lin Chen, Guozhi Jiang, Yu Geng, Wanting Li, Shengxia Yin, Xin Tong, Yue Tao, Jun Ni, Qiuhan Lu, Mingzhe Ning, Chao Wu
SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients. mBio 15 (4) (2024)
Shaoqiu Zhang, Jian Wang, Qun Zhang, Yifan Pan, Zhiyi Zhang, Yu Geng, Bei Jia, Yuanyuan Li, Yali Xiong, Xiaomin Yan, Jie Li, Huali Wang, Chao Wu, Rui Huang
Association of liver function and prognosis in patients with severe fever with thrombocytopenia syndrome. PLoS neglected tropical diseases 18 (4) (2024)
Shaoqiu Zhang, Jian Wang, Qun Zhang, Yifan Pan, Zhiyi Zhang, Yu Geng, Bei Jia, Yuanyuan Li, Yali Xiong, Xiaomin Yan, Jie Li, Huali Wang, Chao Wu, Rui Huang
Association of liver function and prognosis in patients with severe fever with thrombocytopenia syndrome. PLoS neglected tropical diseases 18 (4) (2024)
Yuxin Chen, Tiantian Zhao, Lin Chen, Guozhi Jiang, Yu Geng, Wanting Li, Shengxia Yin, Xin Tong, Yue Tao, Jun Ni, Qiuhan Lu, Mingzhe Ning, Chao Wu
SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients. mBio (2024)
Shaoqiu Zhang, Jian Wang, Qun Zhang, Yifan Pan, Zhiyi Zhang, Yu Geng, Bei Jia, Yuanyuan Li, Yali Xiong, Xiaomin Yan, Jie Li, Huali Wang, Chao Wu, Rui Huang
Association of liver function and prognosis in patients with severe fever with thrombocytopenia syndrome. PLoS neglected tropical diseases 18 (4) (2024)
Jian Wang, Tao Fan, Shaoqiu Zhang, Chao Wu, Rui Huang
Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 59 (8) (2024)
Qi Gu, Shengxia Yin, Xin Tong, Fajuan Rui, Yixuan Zhu, Xiaoyan Ma, Rui Huang, Chao Wu, Jie Li
Current research insights into the role of CTLA-4 in hepatitis B virus (HBV) infection. Journal of viral hepatitis 31 (9) (2024)
Yixuan Zhu, Xiaoming Xu, Zhiwen Fan, Xiaoyan Ma, Fajuan Rui, Wenjing Ni, Xinyu Hu, Qi Gu, Jun-Ping Shi, Chao Wu, Yee Hui Yeo, Jie Li
Different minimal alcohol consumption in male and female individuals with metabolic dysfunction-associated fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 44 (3) (2024)
Yuxin Chen, Tiantian Zhao, Lin Chen, Guozhi Jiang, Yu Geng, Wanting Li, Shengxia Yin, Xin Tong, Yue Tao, Jun Ni, Qiuhan Lu, Mingzhe Ning, Chao Wu
SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients. mBio 15 (4) (2024)
Yixuan Zhu, Xiaoming Xu, Zhiwen Fan, Xiaoyan Ma, Fajuan Rui, Wenjing Ni, Xinyu Hu, Qi Gu, Jun-Ping Shi, Chao Wu, Yee Hui Yeo, Jie Li
Different minimal alcohol consumption in male and female individuals with metabolic dysfunction-associated fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver (2024)
Yuxin Chen, Tiantian Zhao, Lin Chen, Guozhi Jiang, Yu Geng, Wanting Li, Shengxia Yin, Xin Tong, Yue Tao, Jun Ni, Qiuhan Lu, Mingzhe Ning, Chao Wu
SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients. mBio 15 (4) (2024)
Yuxin Chen, Tiantian Zhao, Lin Chen, Guozhi Jiang, Yu Geng, Wanting Li, Shengxia Yin, Xin Tong, Yue Tao, Jun Ni, Qiuhan Lu, Mingzhe Ning, Chao Wu
SARS-CoV-2 Omicron infection augments the magnitude and durability of systemic and mucosal immunity in triple-dose CoronaVac recipients. mBio (2024)
Jian Wang, Yifan Pan, Ye Xiong, Chao Wu, Rui Huang
Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients. Alimentary pharmacology & therapeutics 59 (11) (2024)
Jian Wang, Yifan Pan, Ye Xiong, Chao Wu, Rui Huang
Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients. Alimentary pharmacology & therapeutics 59 (11) (2024)
Jian Wang, Tao Fan, Shaoqiu Zhang, Chao Wu, Rui Huang
Letter: Association of serum growth differentiation factor 15 and liver-related outcomes in patients with MASLD. Alimentary pharmacology & therapeutics 60 (6) (2024)
Yixuan Zhu, Xiaoming Xu, Zhiwen Fan, Xiaoyan Ma, Fajuan Rui, Wenjing Ni, Xinyu Hu, Qi Gu, Jun-Ping Shi, Chao Wu, Yee Hui Yeo, Jie Li
Different minimal alcohol consumption in male and female individuals with metabolic dysfunction-associated fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 44 (3) (2024)
Jian Wang, Tao Fan, Shaoqiu Zhang, Chao Wu, Rui Huang
Letter: Association of serum growth differentiation factor 15 and liver-related outcomes in patients with MASLD. Alimentary pharmacology & therapeutics (2024)
Shaoqiu Zhang, Jian Wang, Qun Zhang, Yifan Pan, Zhiyi Zhang, Yu Geng, Bei Jia, Yuanyuan Li, Yali Xiong, Xiaomin Yan, Jie Li, Huali Wang, Chao Wu, Rui Huang
Association of liver function and prognosis in patients with severe fever with thrombocytopenia syndrome. PLoS neglected tropical diseases 18 (4) (2024)
Jian Wang, Tao Fan, Shaoqiu Zhang, Chao Wu, Rui Huang
Letter: Impact of antiviral treatment on renal function in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 59 (8) (2024)
Jian Wang, Yifan Pan, Ye Xiong, Chao Wu, Rui Huang
Letter: Algorithmic NIT approaches to identify advanced liver fibrosis in patients with MASLD. Alimentary pharmacology & therapeutics (2024)
Jian Wang, Shaoqiu Zhang, Zhiyi Zhang, Chao Wu, Rui Huang
Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D. Alimentary pharmacology & therapeutics 59 (9) (2024)
Rui Huang, Zhiyi Zhang, Jian Wang, Shaoqiu Zhang, Chao Wu
Letter: Association between aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 58 (9) (2023)
Yawen Wan, Minxin Mao, Ming Li, Jiacheng Liu, Xin Tong, Jian Wang, Jie Li, Shengxia Yin, Chao Wu
Serum CXCL16: A new predictor of liver inflammation in patients with chronic hepatitis B. Journal of viral hepatitis 31 (2) (2023)
Rui Huang, Jian Wang, Xiaomin Yan, Chuanwu Zhu, Chao Wu
Letter: improved alanine aminotransferase level in non-cirrhotic and low-viral load chronic hepatitis B patients treated with nucleotide/nucleoside analogues -authors' reply. Alimentary pharmacology & therapeutics 57 (5) (2023)
Jian Wang, Rui Huang, Jiacheng Liu, Ruimin Lai, Yilin Liu, Chuanwu Zhu, Yuanwang Qiu, Zebao He, Shengxia Yin, Yuxin Chen, Xiaomin Yan, Weimao Ding, Qi Zheng, Jie Li, Chao Wu
A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. Journal of viral hepatitis (2023)
Yawen Wan, Minxin Mao, Ming Li, Jiacheng Liu, Xin Tong, Jian Wang, Jie Li, Shengxia Yin, Chao Wu
Serum CXCL16: A new predictor of liver inflammation in patients with chronic hepatitis B. Journal of viral hepatitis 31 (2) (2023)
Jian Wang, Rui Huang, Jiacheng Liu, Ruimin Lai, Yilin Liu, Chuanwu Zhu, Yuanwang Qiu, Zebao He, Shengxia Yin, Yuxin Chen, Xiaomin Yan, Weimao Ding, Qi Zheng, Jie Li, Chao Wu
A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. Journal of viral hepatitis 30 (4) (2023)
Xiaoming Xu, Jiacheng Liu, Chao Wu, Jie Li
Letter: to expand the diagnosis and scale up treatment for patients with chronic hepatitis B-difficult but necessary. Alimentary pharmacology & therapeutics 57 (10) (2023)
Rui Huang, Jian Wang, Xiaomin Yan, Chuanwu Zhu, Chao Wu
Editorial: considerations for expanding treatment in grey zone chronic hepatitis B patients-authors' reply. Alimentary pharmacology & therapeutics 57 (5) (2023)
Jian Wang, Rui Huang, Jiacheng Liu, Ruimin Lai, Yilin Liu, Chuanwu Zhu, Yuanwang Qiu, Zebao He, Shengxia Yin, Yuxin Chen, Xiaomin Yan, Weimao Ding, Qi Zheng, Jie Li, Chao Wu
A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. Journal of viral hepatitis 30 (4) (2023)
Jian Wang, Rui Huang, Jiacheng Liu, Ruimin Lai, Yilin Liu, Chuanwu Zhu, Yuanwang Qiu, Zebao He, Shengxia Yin, Yuxin Chen, Xiaomin Yan, Weimao Ding, Qi Zheng, Jie Li, Chao Wu
A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. Journal of viral hepatitis 30 (4) (2023)
Jian Wang, Rui Huang, Jiacheng Liu, Ruimin Lai, Yilin Liu, Chuanwu Zhu, Yuanwang Qiu, He Zebao, Shengxia Yin, Yuxin Chen, Xiaomin Yan, Weimao Ding, Qi Zheng, Jie Li, Chao Wu
A novel non-invasive model for the prediction of advanced liver fibrosis in chronic hepatitis B patients with NAFLD. Journal of viral hepatitis (2023)
Xiaoming Xu, Jiacheng Liu, Chao Wu, Jie Li
Letter: to expand the diagnosis and scale up treatment for patients with chronic hepatitis B-difficult but necessary. Alimentary pharmacology & therapeutics 57 (10) (2023)
Xiaoming Xu, Jiacheng Liu, Chao Wu, Jie Li
Letter: to expand the diagnosis and scale up treatment for patients with chronic hepatitis B-difficult but necessary. Alimentary pharmacology & therapeutics 57 (10) (2023)
Yawen Wan, Minxin Mao, Ming Li, Jiacheng Liu, Xin Tong, Jian Wang, Jie Li, Shengxia Yin, Chao Wu
Serum CXCL16: A new predictor of liver inflammation in patients with chronic hepatitis B. Journal of viral hepatitis 31 (2) (2023)
Yawen Wan, Minxin Mao, Ming Li, Jiacheng Liu, Xin Tong, Jian Wang, Jie Li, Shengxia Yin, Chao Wu
Serum CXCL16: A new predictor of liver inflammation in patients with chronic hepatitis B. Journal of viral hepatitis (2023)
Xiaoming Xu, Jiacheng Liu, Chao Wu, Jie Li
Letter: to expand the diagnosis and scale up treatment for patients with chronic hepatitis B-difficult but necessary. Alimentary pharmacology & therapeutics 57 (10) (2023)
Tao Ma, Songning Ding, Rui Huang, Hengxue Wang, Junjun Wang, Jiacheng Liu, Jian Wang, Jie Li, Chao Wu, Huafeng Fan, Nan Zhou
The latent period of coronavirus disease 2019 with SARS-CoV-2 B.1.617.2 Delta variant of concern in the postvaccination era. Immunity, inflammation and disease 10 (7) (2022)
Jian Wang, Xiaomin Yan, Li Zhu, Jiacheng Liu, Yuanwang Qiu, Yiguang Li, Yilin Liu, Ruifei Xue, Jie Zhan, Suling Jiang, Yu Geng, Yawen Wan, Ming Li, Minxin Mao, Dongmei Gao, Shengxia Yin, Xin Tong, Juan Xia, Weimao Ding, Yuxin Chen, Jie Li, Chuanwu Zhu, Rui Huang, Chao Wu
Significant histological disease of patients with chronic hepatitis B virus infection in the grey zone. Alimentary pharmacology & therapeutics (2022)
Renling Yao, Li Zhu, Jian Wang, Jiacheng Liu, Ruifei Xue, Leyang Xue, Longgen Liu, Chunyang Li, Haiyan Zhao, Juan Cheng, Songping Huang, Yang Li, Xiang-An Zhao, Chuanwu Zhu, Ming Li, Rui Huang, Chao Wu
Risk of severe illness of COVID-19 patients with NAFLD and increased NAFLD fibrosis scores. Journal of clinical laboratory analysis 35 (8) (2021)
Rui Huang, Jiacheng Liu, Jian Wang, Jie Li, Chao Wu
Letter to the Editor: Is HBV genotype strongly associated with HCC risk in patients with chronic hepatitis B? Hepatology (Baltimore, Md.) (2021)
Xiang-An Zhao, Jian Wang, Jie Wei, Jiacheng Liu, Guangmei Chen, Li Wang, Guiyang Wang, Juan Xia, Weihua Wu, Shengxia Yin, Xin Tong, Xiaomin Yan, Weimao Ding, Xiaoxing Xiang, Rui Huang, Chao Wu
Gamma-glutamyl Transpeptidase to Platelet Ratio Predicts Liver Injury in Hepatitis B e Antigen-negative Chronic Hepatitis B Patients With Normal Alanine Aminotransferase. Journal of clinical and translational hepatology 10 (2) (2021)
Rui Huang, Jiacheng Liu, Jian Wang, Chao Wu
Letter: tenofovir versus entecavir for hepatocellular carcinoma prevention in chronic hepatitis B-related compensated cirrhosis. Alimentary pharmacology & therapeutics 53 (9) (2021)
Rui Huang, Jiacheng Liu, Jian Wang, Xiaomin Yan, Chao Wu
Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B. Alimentary pharmacology & therapeutics 53 (6) (2021)
Rui Huang, Jiacheng Liu, Jian Wang, Chao Wu
Letter: rates and determinants of significant liver inflammation in chronic hepatitis B virus-infected patients with low ALT levels in the absence of significant fibrosis. Alimentary pharmacology & therapeutics 53 (1) (2021)
Kefang Yao, Jian Wang, Lijuan Wang, Juan Xia, Xiaomin Yan, Weihua Wu, Jiacheng Liu, Li Wang, Shengxia Yin, Xin Tong, Weimao Ding, Rui Huang, Chao Wu
Association of anti-HBc and liver inflammation in HBeAg-negative chronic hepatitis B virus-infected patients with normal ALT and detectable HBV DNA. Journal of medical virology 94 (2) (2021)
Jiacheng Liu, Jian Wang, Xiaomin Yan, Ruifei Xue, Jie Zhan, Suling Jiang, Yu Geng, Yilin Liu, Minxin Mao, Juan Xia, Shengxia Yin, Xin Tong, Yuxin Chen, Weimao Ding, Rui Huang, Chao Wu
Presence of Liver Inflammation in Asian Patients With Chronic Hepatitis B With Normal ALT and Detectable HBV DNA in Absence of Liver Fibrosis. Hepatology communications (2021)
Yang Li, Shengxia Yin, Rahma Issa, Xin Tong, Guiyang Wang, Juan Xia, Rui Huang, Guangmei Chen, Dan Weng, Chen Chen, Chao Wu, Yuxin Chen
B Cell-mediated Humoral Immunity in Chronic Hepatitis B Infection. Journal of clinical and translational hepatology 9 (4) (2021)
Jian Wang, Juan Xia, Xiaomin Yan, Yue Yang, Jie Wei, Yali Xiong, Weihua Wu, Yong Liu, Yuxin Chen, Bei Jia, Zhong Chen, Zhaoping Zhang, Weimao Ding, Rui Huang, Chao Wu
Plateletcrit as a potential index for predicting liver fibrosis in chronic hepatitis B. Journal of viral hepatitis 27 (6) (2020)
Rui Huang, Juan Xia, Jian Wang, Yuxin Chen, Chao Wu
Letter: programmed death-1-a predictor for antiviral treatment in chronic hepatitis B. Authors' reply. Alimentary pharmacology & therapeutics 52 (4) (2020)
Yang Li, Shengxia Yin, Yuxin Chen, Quan Zhang, Rui Huang, Bei Jia, Wei Jie, Kefang Yao, Jian Wang, Xin Tong, Yong Liu, Chao Wu
Hepatitis B virus-induced hyperactivation of B cells in chronic hepatitis B patients via TLR4. Journal of cellular and molecular medicine 24 (11) (2020)
Fan-Pu Ji, Jie Li, Li Liu, Jing Liang, Xiaozhong Wang, Junping Liu, Dachuan Cai, Rui Huang, Jiajie Zhang, Qi Wang, Yuemin Nan, Junyi Li, Qing Ye, Mingyuan Zhang, Qiang Xu, Feng Guo, Changqing Zhao, Lingdi Liu, Caini He, Yu Li, Wenjun Wang, Leslie Y Kam, Sally Tran, Mayumi Maeda, Akiko Mizuta, Zongfang Li, Shuangsuo Dang, Wanhua Ren, Qiang Zhu, Ramsey Cheung, Junqi Niu, Wen Xie, Hongying Pan, Hong Ren, Chao Wu, Jia Shang, Fengmei Wang, Mindie H Nguyen
High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b. Journal of gastroenterology and hepatology 36 (3) (2020)
Yang Li, Chunyang Li, Jian Wang, Chuanwu Zhu, Li Zhu, Fang Ji, Longgen Liu, Tianmin Xu, Biao Zhang, Leyang Xue, Xiaomin Yan, Rui Huang, Chao Wu, Xuebing Yan
A case series of COVID-19 patients with chronic hepatitis B virus infection. Journal of medical virology 92 (11) (2020)
Rui Huang, Jian Wang, Xiaomin Yan, Juan Xia, Chao Wu
Letter: risk of developing hepatocellular carcinoma in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation. Alimentary pharmacology & therapeutics 50 (5) (2020)
Li Zhu, Jian Wang, Rui Huang, Longgen Liu, Haiyan Zhao, Chao Wu, Chuanwu Zhu
Clinical characteristics of a case series of children with coronavirus disease 2019. Pediatric pulmonology 55 (6) (2020)
Jian Wang, Li Zhu, Longgen Liu, Xiang-An Zhao, Zhaoping Zhang, Leyang Xue, Xuebing Yan, Songping Huang, Yang Li, Juan Cheng, Biao Zhang, Tianmin Xu, Chunyang Li, Fang Ji, Fang Ming, Yun Zhao, Huaping Shao, Dawen Sang, Haiyan Zhao, Xinying Guan, Xiaobing Chen, Yuxin Chen, Rahma Issa, Jie Wei, Rui Huang, Chuanwu Zhu, Chao Wu
Overweight and Obesity are Risk Factors of Severe Illness in Patients with COVID-19. Obesity (Silver Spring, Md.) 28 (11) (2020)
Jian Wang, Li Zhu, Leyang Xue, Longgen Liu, Xuebing Yan, Xiaomin Yan, Songping Huang, Biao Zhang, Tianmin Xu, Chunyang Li, Fang Ji, Fang Ming, Yun Zhao, Juan Cheng, Huaping Shao, Kang Chen, Xiang-An Zhao, Dawen Sang, Haiyan Zhao, Xinying Guan, Xiaobing Chen, Yuxin Chen, Jiacheng Liu, Rui Huang, Chuanwu Zhu, Chao Wu
Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, China: A retrospective, multi-center study. Journal of medical virology 93 (6) (2020)
Xin Tong, Mingzhe Ning, Rui Huang, Bei Jia, Xiaomin Yan, Yali Xiong, Weihua Wu, Jiacheng Liu, Yuxin Chen, Chao Wu
Surveillance of SARS-CoV-2 infection among frontline health care workers in Wuhan during COVID-19 outbreak. Immunity, inflammation and disease 8 (4) (2020)
Rui Huang, Jian Wang, Juan Xia, Chao Wu
Reply to the letter by Beyan et al "Plateletcrit may not be an index for predicting of liver fibrosis in patients with chronic hepatitis B". Journal of viral hepatitis 27 (7) (2020)
Yuxin Chen, Xin Tong, Yang Li, Bin Gu, Jiawei Yan, Yong Liu, Han Shen, Rui Huang, Chao Wu
A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients. PLoS pathogens 16 (9) (2020)
Juan Xia, Rui Huang, Yuxin Chen, Yong Liu, Jian Wang, Xiaomin Yan, Zhaoping Zhang, Chao Wu
Profiles of serum soluble programmed death-1 and programmed death-ligand 1 levels in chronic hepatitis B virus-infected patients with different disease phases and after anti-viral treatment. Alimentary pharmacology & therapeutics 51 (11) (2020)
Rui Huang, Weihua Wu, Jian Wang, Zhaoping Zhang, Chao Wu
Letter: use of collagen proportionate area to quantify liver fibrosis and predict clinical outcomes in non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 50 (3) (2020)
Rui Huang, Li Zhu, Jian Wang, Leyang Xue, Longgen Liu, Xuebing Yan, Songping Huang, Yang Li, Xiaomin Yan, Biao Zhang, Tianmin Xu, Chunyang Li, Fang Ji, Fang Ming, Yun Zhao, Juan Cheng, Yinling Wang, Haiyan Zhao, Shuqin Hong, Kang Chen, Xiang-An Zhao, Lei Zou, Dawen Sang, Huaping Shao, Xinying Guan, Xiaobing Chen, Yuxin Chen, Jie Wei, Chuanwu Zhu, Chao Wu
Clinical features of COVID-19 patients with non-alcoholic fatty liver disease. Hepatology communications (2020)
Tianmin Xu, Rui Huang, Li Zhu, Jian Wang, Juan Cheng, Biao Zhang, Haiyan Zhao, Kang Chen, Huaping Shao, Chuanwu Zhu, Chao Wu, Longgen Liu
Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection. Journal of medical virology 92 (10) (2020)
Rui Huang, Li Zhu, Leyang Xue, Longgen Liu, Xuebing Yan, Jian Wang, Biao Zhang, Tianmin Xu, Fang Ji, Yun Zhao, Juan Cheng, Yinling Wang, Huaping Shao, Shuqin Hong, Qi Cao, Chunyang Li, Xiang-An Zhao, Lei Zou, Dawen Sang, Haiyan Zhao, Xinying Guan, Xiaobing Chen, Chun Shan, Juan Xia, Yuxin Chen, Xiaomin Yan, Jie Wei, Chuanwu Zhu, Chao Wu
Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study. PLoS neglected tropical diseases 14 (5) (2020)
Rui Huang, Renling Yao, Weihua Wu, Jian Wang, Chao Wu
Letter: distinct hepatitis B virus relapse rates after discontinuing tenofovir and entecavir therapy in chronic hepatitis B patients. Alimentary pharmacology & therapeutics 49 (8) (2020)
Rui Huang, Jian Wang, Weihua Wu, Xiaomin Yan, Chao Wu
Letter: clinical outcomes after long-term entecavir or tenofovir treatment in patients with hepatitis D and advanced fibrosis. Alimentary pharmacology & therapeutics 50 (4) (2020)
R Huang, Z Zhang, J Wang, Y Xiong, Chao Wu
Letter: more studies are needed to elucidate the impact of HBV/HCV coinfection on cirrhosis and its consequences. Alimentary pharmacology & therapeutics 47 (4) (2019)
Xiang-An Zhao, Guangmei Chen, Yong Liu, Hongyan Wu, Jin Chen, Yali Xiong, Chen Tian, Bei Jia, Guiyang Wang, Juan Xia, Yuxin Chen, Jian Wang, Xiaomin Yan, Zhaoping Zhang, Rui Huang, Chao Wu
Emodin Alleviates Liver Fibrosis of Mice by Reducing Infiltration of Gr1hi Monocytes. Evidence-based complementary and alternative medicine : eCAM 2018 (2018)
J Wang, J Xia, R Zhang, X Yan, Y Yang, X Zhao, H Chang, G Wang, G Chen, Y Liu, Y Chen, B Jia, Z Zhang, W Ding, R Huang, Chao Wu
A novel index using routine clinical parameters for predicting significant liver inflammation in chronic hepatitis B. Journal of viral hepatitis 25 (10) (2018)
Bei Jia, Xiaomin Yan, Yuxin Chen, Guiyang Wang, Yong Liu, Biyun Xu, Peixin Song, Yang Li, Yali Xiong, Weihua Wu, Yingying Hao, Juan Xia, Zhaoping Zhang, Rui Huang, Chao Wu
A scoring model for predicting prognosis of patients with severe fever with thrombocytopenia syndrome. PLoS neglected tropical diseases 11 (9) (2017)
R Huang, X Yan, J Xia, J Wang, Chao Wu
Letter: hepatitis B virus reactivation in patients with chronic hepatitis C during direct-acting anti-viral therapy. Alimentary pharmacology & therapeutics 45 (12) (2017)
R Huang, J Wang, Y Hao, X Yan, Chao Wu
Letter: the potential risk of HBV reactivation in patients with resolved HBV infection during direct-acting antiviral therapy. Alimentary pharmacology & therapeutics 46 (7) (2017)
R Huang, J Wang, J Xia, X Yan, Chao Wu
Letter: lipid-lowering effect of tenofovir disoproxil fumarate in chronic hepatitis B-more evidence is needed. Alimentary pharmacology & therapeutics 46 (8) (2017)
Rui Huang, Bei Jia, Guiyang Wang, Chao Wu
Non-invasive fibrosis markers for chronic hepatitis B in sub-Saharan Africa. Liver international : official journal of the International Association for the Study of the Liver 37 (11) (2017)